Comparison of topiramate and placebo in controlling the OCD symptoms of bipolar patients

Not Applicable

• Conditions: Condition 1: Bipolar Mood Disorder. Condition 2: Obsessive-Compulsive disorder.; Bipolar affective disorder, current episode hypomanic; Predominantly obsessional thoughts or ruminations

• Registration Number: IRCT2012061310013N1
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 32

Inclusion Criteria

Fulfilling DSM-IV-TR criteria for bipolar mood disorder; have not Major medical problem ( cardiovascular, respiratory, renal or gastrointestinal disease); not pregnant; not alcohol or other substances abuser; scores >= 18 in Yale- Brown Obsessive Compulsive Scale questionnaire.
Exclusion criteria; failure to cooperate in the ongoing project for the periodical visits; non-qualification for inclusion criteria.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Obsessive-compulsive signs&symptoms in BMD patients. Timepoint: before intervention and then monthly for 4 months. Method of measurement: Yale- Brown Obsessive Compulsive Scale questionaire.

Secondary Outcome Measures

Name	Time	Method
Drug side effects. Timepoint: monthly for 4 months. Method of measurement: checklist of drug side effects.